127 related articles for article (PubMed ID: 37336703)
1. Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder.
Agrawal P; Rostom M; Alam R; Florissi I; Biles M; Rodriguez K; Hahn NM; Johnson BA; Matoso A; Smith A; Bivalacqua TJ; Kates M; Hoffman-Censits J; Patel SH
Clin Genitourin Cancer; 2023 Dec; 21(6):631-638.e1. PubMed ID: 37336703
[TBL] [Abstract][Full Text] [Related]
2. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
[TBL] [Abstract][Full Text] [Related]
3. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base.
Royce TJ; Lin CC; Gray PJ; Shipley WU; Jemal A; Efstathiou JA
Urol Oncol; 2018 Feb; 36(2):78.e1-78.e12. PubMed ID: 29162314
[TBL] [Abstract][Full Text] [Related]
8. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
[No Abstract] [Full Text] [Related]
9. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
Rahman SN; Lokeshwar SD; Syed JS; Javier-Desloges JF; Press BH; Choksi AU; Rajwa P; Pradere B; Ploussard G; Kim JW; Monaghan TF; Renzulli JR; Shariat SF; Leapman MS
Urol Oncol; 2023 Feb; 41(2):107.e1-107.e8. PubMed ID: 36481253
[TBL] [Abstract][Full Text] [Related]
12. MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma.
Huang J; Chen G; Liu H; Jiang W; Mai S; Zhang L; Zeng H; Wu S; Chen CY; Wu Z
Eur Radiol; 2024 Mar; 34(3):1804-1815. PubMed ID: 37658139
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of bladder urothelial carcinoma with squamous differentiation.
Raman JD; Jafri SM
Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
[TBL] [Abstract][Full Text] [Related]
14. Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
Almassi N; Vertosick EA; Sjoberg DD; Wong NC; Huang C; Pietzak EJ; Cha EK; Donahue TF; Dalbagni G; Bochner BH; Iyer G; Rosenberg JE; Bajorin DF; Al-Ahmadie H; Goh AC
BJU Int; 2022 Apr; 129(4):463-469. PubMed ID: 33866683
[TBL] [Abstract][Full Text] [Related]
15. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I
World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
[TBL] [Abstract][Full Text] [Related]
18. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
[TBL] [Abstract][Full Text] [Related]
19. Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy.
Sefik E; Celik S; Basmaci I; Yarımoglu S; Bozkurt IH; Yonguc T; Gunlusoy B
Arch Ital Urol Androl; 2018 Sep; 90(3):172-175. PubMed ID: 30362682
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S
Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
